Payal Kohli - Concepedia

Author

Payal Kohli

Brigham and Women's Hospital ORCID

Also Known As

P Kohli, P. Kohli, Payal Kohli, Payal, Kohli, Promod Kohli

251

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University University of California, San Francisco Thrombolysis in Myocardial Infarction Study Group Amgen (United States)

About

Payal Kohli is an author at Brigham and Women's Hospital specializing in cardiovascular disease, medicine, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	931
2	Public Health	5	5	138
3	Health Sciences	2	2	39
4	Diabetes	2	2	37
5	Emergency Medicine	2	2	91

Payal Kohli

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study Robert P. Giugliano, Nihar R. Desai, Payal Kohli, The Lancet ThrombosisLipid DisorderCardiovascular DiseaseLaplace-timi 57Hyperlipidemia	2012	422
Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness Bruce D. Levy, Payal Kohli, Katherine Gotlinger, The Journal of Immunology	2007	347
Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury Koichi Fukunaga, Payal Kohli, Caroline Bonnans, The Journal of Immunology Acute Lung InjuryInflammatory Lung DiseaseLung InflammationLipid PeroxidationImmunology	2005	276
AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy Nihar R. Desai, Payal Kohli, Robert P. Giugliano, Circulation	2013	174
Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial Payal Kohli, Marc P. Bonaca, Rahul Kakkar, Clinical Chemistry	2011	146
Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study Payal Kohli, Lars Wallentin, Eric Reyes, Circulation	2013	82
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better Omar Mhaimeed, Zain Burney, Stacey L. Schott, American Journal of Preventive Cardiology	2024	79
NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease Payal Kohli, Philippe Gabríel Steg, Christopher P. Cannon, The American Journal of Medicine Stable Atherothrombotic DiseaseThrombosisCardiovascular DiseaseMedicinePharmacotherapy	2013	60
AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients Nihar R. Desai, Robert P. Giugliano, Jing Zhou, Journal of the American College of Cardiology Cardiovascular DiseaseMedicineImmunologyDyslipidemiaLipoprotein Metabolism	2013	51
Clinical Trial Participation After Myocardial Infarction in a National Cardiovascular Data Registry Jacob A. Udell, Tracy Y. Wang, Shuang Li, JAMA Health PolicyCardiovascular DiseaseCoronary UnitClinical TrialsCardiac Care	2014	46

Page 1